K, K., AK, Y., A, R., A, G., S, S., L, J., . . . V, J. (2026). Baseline intact fibroblast growth factor 23 and risk of kidney disease progression in the Indian Chronic Kidney Disease cohort: A prospective multicenter study. Frontiers in medicine, 12, 1707350. https://doi.org/10.3389/fmed.2025.1707350
Chicago Style (17th ed.) CitationK, Kamboj, Yadav AK, Rastogi A, Ghosh A, Sharma S, Jain L, Kumar V, and Jha V. "Baseline Intact Fibroblast Growth Factor 23 and Risk of Kidney Disease Progression in the Indian Chronic Kidney Disease Cohort: A Prospective Multicenter Study." Frontiers in Medicine 12 (2026): 1707350. https://doi.org/10.3389/fmed.2025.1707350.
MLA (9th ed.) CitationK, Kamboj, et al. "Baseline Intact Fibroblast Growth Factor 23 and Risk of Kidney Disease Progression in the Indian Chronic Kidney Disease Cohort: A Prospective Multicenter Study." Frontiers in Medicine, vol. 12, 2026, p. 1707350, https://doi.org/10.3389/fmed.2025.1707350.